InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (38 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
38
T+90 hit rate
14%
T+90 mean return
-30.2%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Paulson Richard A., Chairman & CEO. Insider active across 2 companies, notably Karyopharm Therapeutics Inc.. Aggregated, 49 filings have been logged. Breakdown: 0 buy · 38 sells. Total volume traded: €391k. Activity tracked since 3 May 2021. The latest transaction was filed on 13 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations49 total
4,920 shares0Common StockSEC:0001193125-26-226613:0
4,920 shares0Common StockSEC:0001193125-26-226613
236 shares@ US$7.120.4% of flowCommon StockSEC:0000950170-25-065884:0
245 shares@ US$3.740.2% of flowCommon StockSEC:0000950170-25-051658:0
11,694 shares@ US$6.2917.9% of flowCommon StockSEC:0000950170-25-034736:0
20,000 shares0Common StockSEC:0000950170-25-032297:0
4,099 shares@ US$0.650.7% of flowCommon StockSEC:0000950170-25-014491:0
4,055 shares@ US$0.7830.8% of flowCommon StockSEC:0000950170-25-002819:0
3,620 shares@ US$0.810.7% of flowCommon StockSEC:0000950170-24-133689:0
24,900 shares0Common StockSEC:0001562180-24-007607:0
3,675 shares@ US$0.91060.8% of flowCommon StockSEC:0000950170-24-122274:0
3,607 shares@ US$0.87930.7% of flowCommon StockSEC:0000950170-24-113263:0
3,667 shares@ US$0.72180.6% of flowCommon StockSEC:0000950170-24-104033:0
3,608 shares@ US$0.92990.8% of flowCommon StockSEC:0000950170-24-094087:0
3,616 shares@ US$0.8510.7% of flowCommon StockSEC:0000950170-24-082417:0
3,592 shares@ US$0.990.8% of flowCommon StockSEC:0000950170-24-069856:0
3,576 shares@ US$1.131.0% of flowCommon StockSEC:0000950170-24-054686:0
3,563 shares@ US$1.291.1% of flowCommon StockSEC:0000950170-24-042350:0
3,573 shares@ US$1.301.1% of flowCommon StockSEC:0000950170-24-027153:0
80,470 shares@ US$1.1722.2% of flowCommonSEC:0000950170-24-025188:0
442,800 shares0Common StockSEC:0000950170-24-023281:0
4,012 shares@ US$1.58651.5% of flowCommon StockSEC:0000950170-24-012824:0
42,000 shares0Common StockSEC:0000950170-24-007583:0
4,114 shares@ US$0.820.8% of flowCommon StockSEC:0000950170-24-003177:0
3,622 shares@ US$0.790.7% of flowCommon StockSEC:0001209191-23-057465:0
25 of 49 declarations
About Paulson Richard A.
Richard A. Paulson serves as President and CEO of Karyopharm Therapeutics Inc. He leads the operations of the company, guiding its strategy and growth. His leadership is essential in achieving organizational objectives.
